Raffles Medical Group Ltd
Raffles Medical Group Ltd, commonly referred to as RMG, is a leading integrated healthcare provider headquartered in Singapore (SG). Established in 1976, the company has grown significantly, expanding its operations across Asia, including key markets in China and Vietnam. Operating within the healthcare industry, Raffles Medical Group offers a comprehensive range of services, including primary care, specialist consultations, and hospital services. Its unique approach combines advanced medical technology with patient-centric care, setting it apart in a competitive landscape. Recognised for its commitment to quality, RMG has achieved notable milestones, including the establishment of Raffles Hospital, which is a flagship facility in Singapore. With a strong market position, Raffles Medical Group continues to be a trusted name in healthcare, dedicated to enhancing the well-being of its patients through innovative solutions and exceptional service.
DitchCarbon Score
How does Raffles Medical Group Ltd's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Raffles Medical Group Ltd's score of 36 is higher than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Raffles Medical Group Ltd's reported carbon emissions
In 2024, Raffles Medical Group Ltd, headquartered in Singapore (SG), reported total carbon emissions of approximately 11,996,300 kg CO2e, comprising about 1,197,600 kg CO2e from Scope 1 and about 10,699,700 kg CO2e from Scope 2 emissions. In the previous year, 2023, the Group's emissions were approximately 7,236,600 kg CO2e, with Scope 1 emissions at about 239,900 kg CO2e and Scope 2 emissions at about 6,976,600 kg CO2e. Raffles Medical Group has set ambitious climate commitments, aiming for a 5% reduction in both Scope 1 and Scope 2 emissions by 2030, with a longer-term goal of a 10% reduction by 2050. These targets reflect the Group's commitment to sustainability and align with industry standards for carbon reduction. Additionally, they plan to achieve a 5% reduction in energy consumption intensity by 2035 and a similar reduction in waste generation intensity by 2030. The emissions data for 2023 and 2024 is cascaded from Raffles Medical Group Ltd, which is a current subsidiary. The Group's proactive approach to managing its carbon footprint demonstrates its dedication to addressing climate change and contributing to a more sustainable future.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2023 | 2024 | |
|---|---|---|
| Scope 1 | 1,644,900 | 0,000,000 |
| Scope 2 | 17,489,200 | 00,000,000 |
| Scope 3 | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Raffles Medical Group Ltd is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
